← All companies

CMPS

COMPASS Pathways plc

CMPS Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.25

-0.32 -2.77%

Key statistics

from XBRL data in SEC filings

Market cap

$1.52B

Revenue (TTM)

—

Net income (TTM)

-$161M

EPS (TTM)

$-3.14

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$466M

Total assets

$532M

Gross margin

—

52-week range

$3.97 – $15.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jul 7, 2026 8-K Shareholder vote results May 28, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 24, 2026 8-K Results of operations (earnings release) Mar 24, 2026 8-K Entered a material agreement; Regulation FD disclosure Feb 19, 2026 8-K Regulation FD disclosure; Other events Feb 17, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Director or officer change Oct 29, 2025 8-K Results of operations (earnings release) Jul 31, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Director or officer change Jul 29, 2025 8-K Other events Jun 23, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Changed accountants; Director or officer change Apr 16, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Jan 10, 2025 8-K Results of operations (earnings release) Oct 31, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release); Director or officer change Aug 1, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Shareholder vote results; Other events May 9, 2024 8-K Results of operations (earnings release) May 8, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Other events May 8, 2024 8-K Director or officer change; Regulation FD disclosure Mar 28, 2024 8-K Results of operations (earnings release) Feb 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Director or officer change; Regulation FD disclosure Dec 7, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Director or officer change; Regulation FD disclosure Oct 26, 2023 8-K Director or officer change; Regulation FD disclosure Sep 18, 2023 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 16, 2023